Last reviewed · How we verify

NCT05709236

Digital Versus Conventional Full-arch Implant Impression in Maxillary Screw- Retained Implant Prosthesis

Completed NA Last updated 2 February 2023
What this trial tests

NA trial testing Maxillary screw-retained prosthesis in Jaw, Edentulous in 28 participants. Completed in 10 August 2022.

Timeline
5 January 2020
Primary endpoint
10 May 2022
10 August 2022

Quick facts

Lead sponsorDelta University for Science and Technology
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment28
Start date5 January 2020
Primary completion10 May 2022
Estimated completion10 August 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Delta University for Science and Technology

Who can join

Adults 56 to 70, any sex, with Jaw, Edentulous. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

28 participants with edentulous maxillary arches were randomly selected and enrolled in two equal groups; Group I conventional impression group (CIG) and Group II Digital impression group (DIG). All patients were rehabilitated with maxillary screw-retained implant prosthesis retained by 6 implants. Prosthodontic complications and peri-implant MBL were registered at 6,12, and 24 months (m). Data was collected and statistically analyzed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Jaw, Edentulous

Currently open trials in the same condition.

Other Delta University for Science and Technology trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05709236.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing